首页> 外文期刊>Regulatory peptides. >Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.
【24h】

Plasma adrenomedullin and endothelin-1 concentration during low-dose dobutamine infusion: Relationship between pulmonary uptake and pulmonary vascular pressure/flow characteristics.

机译:小剂量多巴酚丁胺输注期间血浆肾上腺髓质素和内皮素-1浓度:肺摄取与肺血管压力/流量特征之间的关系。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

AIM: To study the role of endothelin (ET-1) and adrenomedullin (AM) on pulmonary vascular pressure/flow characteristic (pulmonary arterial pressure/cardiac output (Pap/CO)) during low-dose dobutamine infusion. METHODS: Case control study of 14 patients (12 men, 2 women) with severe lung disease (chronic obstructive pulmonary disease, COPD n=5; cystic fibrosis, CF n=9) and 5 control subjects (CTRL, 4 men, 1 woman). ET-1 and AM plasma levels in pulmonary artery (mixed venous blood, ven) and aorta or femoral artery (arterial, art), were measured at baseline and during dobutamine infusion (5-10-15 mcg kg(-1) min(-1)). The Ppa/CO coordinates obtained at baseline and during dobutamina infusion for each patients were used to calculate the Slope and Intercept by linear regression analysis. RESULTS: Baseline hemodynamics measurements were similar in the three groups with a trend towards a mild elevation in Ppa in CF group (Ppa mm Hg: CTRL 19+/-3.5, COPD 19.4+/-5.5, CF 22.7+/-7.5). Baseline plasma ET-1(ET-1ven pg ml(-1): CTRL 13.9+/-6.7, COPD 20.1+/-14, CF 20.4+/-7.1; ET-1art pg ml(-1): CTRL 16.7+/-6.4, COPD 20.1+/-11.7, CF 18.1+/-3.9) and AM (AMven pg ml(-1): CTRL 15.8+/-5, COPD 31.8+/-17.6, CF 27.7+/-7.6; AMart pg ml(-1): CTRL 15.9+/-1.4, COPD 21.4+/-3.8, CF 27+/-7.6) showed a trend towards higher value among patients' groups compared to the controls. Baseline ET-1 pulmonary gradient did not show significant difference among the three groups as well AM pulmonary gradient. Dobutamine infusion caused a comparable increase of heart rate and CO in the three groups. Mean pulmonary pressure had a trend towards a greater increase in COPD and CF than in controls, consequently, pulmonary Pap/CO relationship showed a steeper slope in patients' groups (Slope mm Hg L(-1) min(-1): CTRL 0.9+/-0.3, COPD 2.1+/-0.8 p<0.02 vs. CTRL, CF 1.9+/-0.9 p<0.03 vs CTRL). During dobutamine plasma ET-1 and AM showed a great individual variability resulting in no significant difference among groups. ET-1 pulmonary gradient showed a trend towards pulmonary uptake in patients' groups (ET-1art-ven pg min(-1): CTRL 2.7+/-2.9, COPD-6.1+/-7.8, CF -4+/-4.8) while AM pulmonary gradient did not show any particular pattern. During dobutamine ET-1 was significantly correlated to Pap/CO characteristics (Slope and ET-1ven, r=-0.59, p<0.05; Slope and ET-1art-ven, r=-0.60, p<0.05; Intercept and ET-1art-ven, r=0.63, p<0.004), and ET-1art-ven was the only independent variable related to Slope and Intercept. CONCLUSIONS: In patients with moderate pulmonary vascular impairment, ET-1 pulmonary gradient, but not AM pulmonary gradient, is inversely correlated with pulmonary incremental resistance, suggesting a role of ET-1 in the regulation of pulmonary vascular resistance.
机译:目的:研究低剂量多巴酚丁胺输注期间内皮素(ET-1)和肾上腺髓质素(AM)对肺血管压力/流量特征(肺动脉压/心输出量(Pap / CO))的作用。方法:病例对照研究对14例重度肺部疾病(慢性阻塞性肺疾病,COPD n = 5;囊性纤维化,CF n = 9)和5例对照受试者(CTRL,4例,1例)进行了病例对照研究)。在基线和多巴酚丁胺输注期间(5-10-15 mcg kg(-1)min(分钟),测量肺动脉(混合静脉血,静脉)和​​主动脉或股动脉(动脉,动脉)的ET-1和AM血浆水平-1))。每位患者在基线和多巴汀治疗期间获得的Ppa / CO坐标用于通过线性回归分析计算斜率和截距。结果:三组的基线血流动力学测量结果相似,CF组的Ppa呈轻度升高趋势(Ppa mm Hg:CTRL 19 +/- 3.5,COPD 19.4 +/- 5.5,CF 22.7 +/- 7.5)。基线血浆ET-1(ET-1ven pg ml(-1):CTRL 13.9 +/- 6.7,COPD 20.1 +/- 14,CF 20.4 +/- 7.1; ET-1art pg ml(-1):CTRL 16.7+ /-6.4、COPD 20.1 +/- 11.7,CF 18.1 +/- 3.9)和AM(AMven pg ml(-1):CTRL 15.8 +/- 5,COPD 31.8 +/- 17.6,CF 27.7 +/- 7.6;与对照组相比,AMart pg ml(-1):CTRL 15.9 +/- 1.4,COPD 21.4 +/- 3.8,CF 27 +/- 7.6)显示出患者组中的价值更高的趋势。基线ET-1肺梯度和AM肺梯度在三组之间没有显着差异。三组中多巴酚丁胺的注入导致心率和CO的增加相当。平均肺压比对照组的COPD和CF有增加的趋势,因此,肺部Pap / CO关系显示患者组的斜率更陡(斜率mm Hg L(-1)min(-1):CTRL 0.9 +/- 0.3,COPD相对于CTRL为2.1 +/- 0.8 p <0.02,CF相对于CTRL为1.9 +/- 0.9 p <0.03)。在多巴酚丁胺治疗期间,血浆ET-1和AM表现出很大的个体变异性,各组之间无显着差异。 ET-1肺梯度显示患者组有肺摄取趋势(ET-1art-ven pg min(-1):CTRL 2.7 +/- 2.9,COPD-6.1 +/- 7.8,CF -4 +/- 4.8 ),而AM肺梯度未显示任何特定模式。在多巴酚丁胺期间,ET-1与Pap / CO特性显着相关(坡度和ET-1ven,r = -0.59,p <0.05;坡度和ET-1art-ven,r = -0.60,p <0.05;截距和ET- 1art-ven,r = 0.63,p <0.004),而ET-1art-ven是与坡度和截距相关的唯一自变量。结论:在中度肺血管损害患者中,ET-1肺梯度而不是AM肺梯度与肺增量阻力成反比,提示ET-1在调节肺血管阻力中具有作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号